Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 3, 2003, Pages 616-625

  Taylor, N A ^a   Liao, Zhongxing X ^a   Stevens, C ^a   Walsh, G ^a   Roth, J ^a   Putnam Jr , J ^a   Fossella, F ^a   Allen, P ^a   Cox, J D ^a   Komaki, R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Induction chemotherapy; Non small cell lung cancer; Postoperative radiotherapy; Surgery

Indexed keywords

CHEMOTHERAPY; PULMONARY DISEASES; TUMORS;

INDUCTION CHEMOTHERAPY;

RADIOTHERAPY;

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; MITOMYCIN; PACLITAXEL; VINBLASTINE SULFATE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; DISEASE SEVERITY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

EID: 0037944117     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00063-4     Document Type: Article

References (37)

1. Goldstraw P., Mannam G.C., Kaplan D.K., et al. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg. 107:1994;19-28.
2. Mountain C.F. Surgery for stage IIIa-N2 non-small cell lung cancer. Cancer. 73:1994;2589-2598.
3. Meko J., Rusch V.W. Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer. Semin Radiat Oncol. 10:2000;324-332.
4. Sawyer T.E., Bonner J.A., Gould P.M., et al. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement. Cancer. 80:1997;1399-1408.
5. Emami B., Kaiser L., Simpson J., et al. Postoperative radiation therapy in non-small cell lung cancer. Am J Clin Oncol. 20:1997;441-448.
6. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med. 315:1986;1377-1381.
7. Feng Q.F., Wang M., Wang L.J., et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer A randomized trial . Int J Radiat Oncol Biol Phys. 47:2000;925-929.
8. Mayer R., Smolle-Juettner F.M., Szolar D., et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest. 112:1997;954-959.
9. Stephens R.J., Girling D.J., Bleehen N.M., et al. The role of post-operative radiotherapy in non-small-cell lung cancer A multicentre randomized trial in patients with pathologically staged T1-2, N1-2, M0 disease . Br J Cancer. 74:1996;632-639.
10. Rosell R., Gomez-Codina J., Camps C., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 330:1994;153-158.
11. Roth J.A., Fossella F., Komaki R., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst. 86:1994;673-680.
12. Fleming I.D. AJCC cancer staging manual. 5th ed:1997;Lippincott-Raven, Philadelphia.
13. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
14. Martini N., Flehinger B.J., Zaman M.B., et al. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg. 198:1983;386-397.
15. Durci M.L., Komaki R., Oswald M.J., et al. Comparison of surgery and radiation therapy for non-small cell carcinoma of the lung with mediastinal metastasis. Int J Radiat Oncol Biol Phys. 21:1991;629-636.
16. Walsh G.L., O'Connor M., Willis K.M., et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg. 60:1995;1563-1572.
17. Goldie J.H. Scientific basis for adjuvant and primary (neoadjuvant) chemotherapy. Semin Oncol. 14:1987;1-7.
18. Martini N., Kris M.G., Flehinger B.J., et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer The Sloan-Kettering experience with 136 patients . Ann Thorac Surg. 55:1993;1365-1374.
19. Burkes R.L., Ginsberg R.J., Shepherd F.A., et al. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer Results of the Toronto phase II trial . J Clin Oncol. 10:1992;580-586.
20. Sugarbaker D.J., Herndon J., Kohman L.J., et al. Results of Cancer and Leukemia Group B protocol 8935 A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer . J Thorac Cardiovasc Surg. 109:1995;473-485.
21. Rosell R., Gomez-Codina J., Camps C., et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer A 7-year assessment of a randomized controlled trial . Lung Cancer. 26:1999;7-14.
22. Roth J.A., Atkinson E.N., Fossella F., et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer Inst. 21:1998;1-6.
23. Pisters K.M., Ginsberg R.J., Putnam J.B. Jr, et al. Induction chemotherapy before surgery for early-stage lung cancer A novel approach . J Thorac Cardiovasc Surg. 119:2000;423-439.
24. Depierre A., Milleron B., Moro D., et al. Phase III trial of neo-adjuvant chemotherapy in resectable stage I (except T1N0), II and IIIa non-small cell lung cancer The French experience . Proc Am Soc Clin Oncol. 18:1999;465a.
25. Depierre A., Milleron B., Moro-Sibilot D., et al. Preoperative chemotherapy followed by surgery compared to primary surgery in resectable stage I (except T1N0), II, and IIIA non-small cell lung cancer. J Clin Oncol. 20:2002;247-253.
26. Pass H.I., Pogrebniak H.W., Steinberg S.M., et al. Randomized trial of neoadjuvant therapy for lung cancer Interim analysis . Ann Thorac Surg. 53:1992;992-998.
27. Elias A.D. A phase II comparison of best local-regional therapy with or without chemotherapy for stage IIIA non-small cell lung cancer. Proc Am Soc Clin Oncol. 16:1997;448A. [Abstract].
28. Kirn D.H., Lynch T.J., Mentzer S.J., et al. Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer Impact of preoperative chemotherapy on resectability and downstaging . J Thorac Cardiovasc Surg. 106:1993;696-702.
29. Rube C., Phu Nguyen T., Fleckenstein J., et al. Postoperative radiotherapy in localized non-small cell lung cancer. Lung Cancer. 33:(Suppl. 1):2001;S29-S33.
30. Van Houtte P. NSCLC: Surgery and postoperative radiotherapy. 1996;Lippincott-Raven, Philadelphia.
31. Dautzenberg B., Arriagada R., Chammard A.B., et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer. 86:1999;265-273.
32. Bonner J.A. The role of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma Seeking to optimize local control and survival while minimizing toxicity . Cancer. 86:1999;195-196.
33. Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev. 2:2000;. (Issue CD002142).
34. Wagner H. Jr. Postoperative adjuvant therapy for patients with resected non-small cell lung cancer Still controversial after all these years . Chest. 117:(4 Suppl. 1):2000;110S-118S.
35. Sawyer T.E., Bonner J.H. Postoperative radiotherapy in NSCLC. Semin Radiat Oncol. 10:2000;280-288.
36. Keller S.M., Adak S., Wagner H., et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. N Engl J Med. 343:2000;1217-1222.
37. Schilder R.J., Goldberg M., Millenson M.M., et al. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung. Lung Cancer. 27:2000;37-45.